VJOncology Podcast
VJOncology Podcast
VJOncology
GI cancer highlights at ESMO 2025: FORTITUDE-101, STELLAR-303, and more
21 minutes Posted Nov 28, 2025 at 11:56 am.
Introduction to ESMO 2025 Updates
Fortitude 101 Trial Insights
ASP2138: Phase 1-2b Trial Results
Cassandra Trial: Chemotherapy Approaches
IMPRAE 152: Teregulamab and Treatment Evaluation
STILAR 303: Immunotherapy Breakthroughs
0:00
21:13
Download MP3
Show notes

In this week’s VJOncology podcast, we have the pleasure to bring you key updates in gastrointestinal cancer at ESMO 2025, which we attended live in Berlin. Join esteemed experts Kohei Shitara, MD, National Cancer Center Hospital East, Kashiwa, Japan, Michele Reni, MD, IRCCS San Raffaele Scientific Institute, Milan, Italy, Stephen Lam Chan, MD, FRCP, Chinese University of Hong Kong, Hong Kong, China, and Anwaar Saeed, MD, University of Pittsburgh, Pittsburgh, PA, as they discuss ground-breaking trials such as FORTITUDE-101, CASSANDRA, STELLAR-303, and more.